About Interpace Biosciences

Interpace Biosciences (OTCQX: IDXG) is a leader in enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications.

Interpace Diagnostics is a fully integrated commercial and bioinformatics business unit that provides clinically useful molecular diagnostic tests, bioinformatics and pathology services for evaluating risk of cancer by leveraging the latest technology in personalized medicine for improved patient diagnosis and management.

Interpace Pharma Solutions provides pharmacogenomics testing, genotyping, biorepository and other customized services to the pharmaceutical and biotech industries and advances personalized medicine by partnering with pharmaceutical, academic, and technology leaders to effectively integrate pharmacogenomics into their drug development and clinical trial programs with the goals of delivering safer, more effective drugs to market more quickly, and improving patient care.

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Location
300 Interpace Pkwy, Parsippany, New Jersey 07054, US
description icon
Keywords
Molecular Diagnostics And Personalized Medicine

Interpace Biosciences Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
Biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about Interpace Biosciences

Who is the CEO of Interpace Biosciences?

Tom Burnell is the CEO of Interpace Biosciences. To contact Tom Burnell email at [email protected]. Or you may call +1.4026134184

Who are the decision makers in Interpace Biosciences?

The decision makers in Interpace Biosciences are Boaz Kurtis, Christopher Mccarthy, Ginette Halvorsen, etc. Click to Find Interpace Biosciences decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more